Molecular Bases and Specificity behind the Activation of the Immune System OAS/RNAse L Pathway by Viral RNA.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
02 Aug 2024
Historique:
received: 08 07 2024
revised: 31 07 2024
accepted: 01 08 2024
medline: 1 9 2024
pubmed: 31 8 2024
entrez: 29 8 2024
Statut: epublish

Résumé

The first line of defense against invading pathogens usually relies on innate immune systems. In this context, the recognition of exogenous RNA structures is primordial to fight, notably, against RNA viruses. One of the most efficient immune response pathways is based on the sensing of RNA double helical motifs by the oligoadenylate synthase (OAS) proteins, which in turn triggers the activity of RNase L and, thus, cleaves cellular and viral RNA. In this contribution, by using long-range molecular dynamics simulations, complemented with enhanced sampling techniques, we elucidate the structural features leading to the activation of OAS by interaction with a model double-strand RNA oligomer mimicking a viral RNA. We characterize the allosteric regulation induced by the nucleic acid leading to the population of the active form of the protein. Furthermore, we also identify the free energy profile connected to the active vs. inactive conformational transitions in the presence and absence of RNA. Finally, the role of two RNA mutations, identified as able to downregulate OAS activation, in shaping the protein/nucleic acid interface and the conformational landscape of OAS is also analyzed.

Identifiants

pubmed: 39205220
pii: v16081246
doi: 10.3390/v16081246
pii:
doi:

Substances chimiques

RNA, Viral 0
2-5A-dependent ribonuclease EC 3.1.26.-
2',5'-Oligoadenylate Synthetase EC 2.7.7.84
Endoribonucleases EC 3.1.-
RNA, Double-Stranded 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Emma Jung-Rodriguez (E)

Université Paris Cité and CNR, ITODYS, F-75006 Paris, France.

Florent Barbault (F)

Université Paris Cité and CNR, ITODYS, F-75006 Paris, France.

Emmanuelle Bignon (E)

Université de Lorraine and CNRS, LPCT UMR 7019, F-54000 Nancy, France.

Antonio Monari (A)

Université Paris Cité and CNR, ITODYS, F-75006 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH